{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T17:03:18Z","timestamp":1782147798348,"version":"3.54.5"},"reference-count":34,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,9,19]],"date-time":"2007-09-19T00:00:00Z","timestamp":1190160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Otolaryngology"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:p><jats:bold>Background and objectives of review:\u2002<\/jats:bold> The use of aminoglycoside drops in the presence of a perforation\/grommet is still a common practice amongst the UK ENT community, in spite of theoretical risk of ototoxicity. Mindful of the need to produce clinical guidelines based on the best available evidence, it was the intention of the Clinical Audit and Practice Advisory Group of the British Association of Otolaryngologists \u2013 Head and Neck Surgeons (ENT\u2010UK) to produce evidence\u2010based guidelines. In the absence of good evidence, intentions were shifted towards producing consensus guidelines using validated methodology.<\/jats:p><jats:p><jats:bold>Type of review:\u2002<\/jats:bold> Literature review, review of international guidelines and consensus guidelines.<\/jats:p><jats:p><jats:bold>Search strategy:\u2002<\/jats:bold> A MEDLINE literature search (1966 to August 2006) was conducted, using the following strategies: \u2018ototoxicity and drops\u2019, \u2018ototoxic and drops\u2019, \u2018vestibulotoxicity and drops\u2019, \u2018vestibulotoxic and drops\u2019, \u2018cochleotoxicity and drops\u2019, \u2018cochleotoxic and drops\u2019. Foreign language articles were not excluded.<\/jats:p><jats:p><jats:bold>Results of the literature review:\u2002<\/jats:bold> The inclusion of foreign language articles and manually searching the reference sections of identified articles revealed further evidence not considered in previous reviews on this subject. However, the available \u2018evidence\u2019 that does exist remains to be of poor quality, consisting of data from a number of case reports and small case series. Prospective studies into the ototoxic effects of aminoglycoside ear drops either support their use but lack power to statistically confirm this, or are performed in conditions that are not representative of normal clinical conditions.<\/jats:p><jats:p><jats:bold>Evaluation method:\u2002<\/jats:bold> In the light of issues raised from the literature review, a questionnaire was produced. The questionnaire was initially completed by council members of the British Society of Otology, then revised and presented at a meeting of the British Society of Otology, where a consensus panel was formed.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> ENT\u2010UK recommends that when treating a patient with a discharging ear, in whom there is a perforation or patent grommet: if a topical aminoglycoside is used, this should only be in the presence of obvious infection. Topical aminoglycosides should be used for no longer than 2\u2003weeks. The justification for using topical aminoglycosides should be explained to the patient. Baseline audiometry should be performed, if possible or practical, before treatment with topical aminoglycosides.<\/jats:p>","DOI":"10.1111\/j.1749-4486.2007.01532.x","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T10:24:33Z","timestamp":1284459873000},"page":"330-336","source":"Crossref","is-referenced-by-count":49,"title":["Evidence review and ENT\u2010UK consensus report for the use of aminoglycoside\u2010containing ear drops in the presence of an open middle ear"],"prefix":"10.1111","volume":"32","author":[{"given":"J.S.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.W.","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.R.C.","family":"Swan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,9,19]]},"reference":[{"key":"e_1_2_12_2_2","first-page":"293","article-title":"Experimental evidence of ototoxicity of ear drops. A review of the literature","volume":"49","author":"Kuhweide R.","year":"1995","journal-title":"Acta. Otorhinolaryngol. Belg."},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/019459989411000623"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004618.pub2"},{"key":"e_1_2_12_5_2","doi-asserted-by":"crossref","unstructured":"BrowningG.G. GatehouseS.&CalderI.T.(1988)Medical management of active chronic otitis media: a controlled study.J. Laryngol. Otol.102 491\u2013495","DOI":"10.1017\/S0022215100105444"},{"key":"e_1_2_12_6_2","first-page":"367","article-title":"Controlled trial of gentamicin and hydrocortisone ear drops in the treatment of active chronic otitis media","volume":"8","author":"Picozzi G.","year":"1983","journal-title":"Clin. Otolaryngol."},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1991.tb01963.x"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6398.1024"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.129.10.1098"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2003.12.007"},{"key":"e_1_2_12_11_2","first-page":"444","article-title":"Topical gentamicin vestibular toxicity","volume":"23","author":"Longridge N.S.","year":"1994","journal-title":"J. Otolaryngol."},{"key":"e_1_2_12_12_2","first-page":"850","article-title":"Topical gentamicin\u2010induced hearing loss: a mitochondrial ribosomal RNA study of genetic susceptibility","volume":"17","author":"Chen J.M.","year":"1996","journal-title":"Am. J. Otol."},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.1998.00161.x"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199907000-00015"},{"key":"e_1_2_12_15_2","first-page":"357","article-title":"Risk of deafness following ototopical administration of aminoglycoside antibiotic (author's transl)","volume":"35","author":"Dumas G.","year":"1980","journal-title":"Therapie"},{"key":"e_1_2_12_16_2","first-page":"653","article-title":"Ototoxicity of ear drops: a clinical perspective","volume":"16","author":"Linder T.E.","year":"1995","journal-title":"Am. J. Otol."},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000275842"},{"key":"e_1_2_12_18_2","first-page":"353","article-title":"[Topical ototoxicity: review over a 6\u2010year period]","volume":"49","author":"Abello P.","year":"1998","journal-title":"Acta Otorrinolaringol. Esp."},{"key":"e_1_2_12_19_2","first-page":"19","article-title":"Ototoxicity of ear drops","volume":"29","author":"Martin H.","year":"1980","journal-title":"J. Fr. Otorhinolaryngol. Audiophonol. Chir. Maxillofac."},{"key":"e_1_2_12_20_2","first-page":"49","article-title":"[Risk of inner ear damage from ototoxic eardrops]","volume":"26","author":"Kellerhals B.","year":"1978","journal-title":"HNO"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100148157"},{"key":"e_1_2_12_22_2","first-page":"1","article-title":"Otological significance of the round window","volume":"33","author":"Nomura Y.","year":"1984","journal-title":"Adv. Otorhinolaryngol."},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00125817-200209000-00004"},{"key":"e_1_2_12_24_2","first-page":"194","article-title":"Safety of topical ear drops containing ototoxic antibiotics","volume":"26","author":"Rakover Y.","year":"1997","journal-title":"J. Otolaryngol."},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-199505000-00003"},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/019459989310900114"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.1017\/S002221510014558X"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200204000-00018"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100108011"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2003.12.010"},{"issue":"4","key":"e_1_2_12_31_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/01455613040839s405","article-title":"Consensus panel on role of potentially ototoxic antibiotics for topical middle ear use. Summary of the findings of a joint consensus panel on the use of potentially ototoxic ototopicals","volume":"83","author":"Roland P.S.","year":"2004","journal-title":"Ear Nose Throat J."},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2006.02.014"},{"key":"e_1_2_12_33_2","volume-title":"Anti\u2010Infective Guidelines for Community\u2010Acquired Infections","author":"Rosser W.","year":"2005"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7517.631"},{"key":"e_1_2_12_35_2","article-title":"Use of aminoglycoside\u2010containing ear drops in the presence of a perforation: evidence review and ENT\u2010UK consensus statement","author":"Phillips J.S.","year":"2007","journal-title":"Clinical Audit and Practice Advisory Group Guidelines, British Association of Otolaryngologists \u2013 Head & Neck Surgeons (ENT-UK)"}],"container-title":["Clinical Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-4486.2007.01532.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-4486.2007.01532.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T21:53:46Z","timestamp":1695938026000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-4486.2007.01532.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,19]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1749-4486.2007.01532.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-4486.2007.01532.x","archive":["Portico"],"relation":{},"ISSN":["1749-4478","1749-4486"],"issn-type":[{"value":"1749-4478","type":"print"},{"value":"1749-4486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,19]]}}}